FDA Orange Book

Is there a generic for Sephience?

Sephience contains sepiapterin. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.

Source: FDA Orange Book data file dated 2026-10-09. Publisher page

No. The Orange Book lists no active FDA-approved generic (ANDA) for Sephience (sepiapterin). The Orange Book shows its last listed patent expires March 6, 2042 and its last listed exclusivity ends July 28, 2032.

Run it in Rivvi

Map Sephience and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Sephience products in the Orange Book

Sephience products and approved generics
Form and routeStrengthBrand statusBrand TEActive genericsGeneric TE codes
powder, oral1GM/PACKETMarketed (Rx)None0None
powder, oral250MG/PACKETMarketed (Rx)None0None

NDA 219666, held by PTC THERAPEUTICS INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.

Sephience patents

Patents listed for Sephience
PatentExpiresCoversUse codeNDA
11072614April 16, 2038Drug substanceU-4251219666
12213982September 4, 2038Method of useU-4251219666
11752154September 4, 2038Drug productU-4251219666
12257252March 6, 2042Method of useU-4250219666

Sephience exclusivity

Exclusivity listed for Sephience
CodeMeaningExpiresNDA
NCENew chemical entityJuly 28, 2030219666
ODE-542Orphan drug exclusivityJuly 28, 2032219666

Sephience NDC codes

Questions

Is there a generic for Sephience?

No. The Orange Book lists no active FDA-approved generic (ANDA) for Sephience (sepiapterin). The Orange Book shows its last listed patent expires March 6, 2042 and its last listed exclusivity ends July 28, 2032.

What is the generic name for Sephience?

The active ingredient in Sephience is sepiapterin, per the FDA Orange Book.

When does the Sephience patent expire?

The last patent listed for Sephience in the Orange Book expires March 6, 2042. A listed patent expiry date is not a generic launch date.

What does a therapeutic equivalence code mean?

In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.

More on Sephience and Sepiapterin

Try it on your own data today.

Free to start. Most teams are using it the same day.